| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.31 | 0.09 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.09 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.099 | 0.09 |